Tepkinly 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

tepkinly

abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastična sredstva - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.

Tyenne 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

tyenne

fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - imunosupresivi - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.

Constella 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

constella

abbvie deutschland gmbh & co. kg - linaclotide - razdražljiv crijevni sindrom - lijekovi za zatvor - constella je indiciran a za simptomatsko liječenje umjerenog do teškog sindroma iritabilnog crijeva s zatvor (ibs-c) u odraslih.

Lumigan 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

lumigan

abbvie deutschland gmbh & co. kg - bimatoprost - glaucoma, open-angle; ocular hypertension - prostaglandin analogues, ophthalmologicals - smanjenje povišenog intraokularnog tlaka u kroničnom otvorenom kutu glaukoma i očne hipertenzije (kao monoterapija ili kao dodatna terapija beta-blokatora).

Insulin Human Winthrop 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - Šećerna bolest - lijekovi koji se koriste u dijabetesu - diabetes mellitus gdje je potrebno liječenje inzulinom. inzulin ljudske winthrop rapid je pogodan za liječenje hiperglikemijsku komu i ketoacidoza, kao i za postizanje unaprijed, intra - i postoperativna stabilizacija u bolesnika sa šećernom bolešću.

Insuman 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

insuman

sanofi-aventis deutschland gmbh - insulin human - Šećerna bolest - lijekovi koji se koriste u dijabetesu - diabetes mellitus gdje je potrebno liječenje inzulinom. insuman rapid je pogodan za liječenje hiperglikemijsku komu i ketoacidoza, kao i za postizanje unaprijed, intra - i postoperativna stabilizacija u bolesnika sa šećernom bolešću.

Civaron 136 mmol/l otopina za infuziju 크로아티아 - 크로아티아어 - HALMED (Agencija za lijekove i medicinske proizvode)

civaron 136 mmol/l otopina za infuziju

fresenius medical care deutschland gmbh, else kröner str.1, bad homburg, njemačka - natrijev citrat dihidrat - otopina za infuziju - urbroj: 1000 ml otopine sadrži 40,0 g natrijevog citrata (odgovara 408 mmol natrija i 136 mmol citrata)

SRP 크로아티아 - 크로아티아어 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

srp

wirtschaftsgenossenschaft deutscher tieraerzte eg, siemensstrasse 14, 30827 garbsen, njemačka - filmom obložena tableta - vitofyllin 50 mg - qc04ad90

SRP 크로아티아 - 크로아티아어 - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

srp

wirtschaftsgenossenschaft deutscher tieraerzte eg, siemensstrasse 14, 30827 garbsen, njemačka - filmom obložena tableta - vitofyllin 100 mg - qc04ad90

Stocrin 유럽 연합 - 크로아티아어 - EMA (European Medicines Agency)

stocrin

merck sharp & dohme b.v. - efavirenz - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - stocrin je indiciran u antivirusnom kombiniranom tretmanu odraslih, adolescenata i djece starijih od tri godine starijih od ljudske imunodeficijencije-1 (hiv-1). Стокрин nisu bili pravilno istražena u bolesnika s uznapredovalom faze infekcije hiv-om, a upravo je u bolesnika s razinom cd4 < 50 ćelija/mm3, ili nakon neuspjeha протеаза-inhibitora (pi)-sadrže sheme. iako je cross-otpornost эфавиренза sa ip nije bio registriran, trenutno nema dovoljno podataka o efikasnosti kasniju upotrebu pi na temelju kombinirane terapije neučinkovitosti sheme sadrže Стокрин.